The disease Amlapitta is a frequent presentation in clinical practice. Excess formation of vitiated pitta (Pitta Drava guna vridhi) due improper dietary and lifestyle habits is thought to be the main pathological mechanism behind manifestation of this disease. Classical Ayurvedic formulations like Avipattikar choorna and sutasekhar Rasa are often prescribed in combination for its effective management. The present study was conducted to evaluate the efficacy of both these classical formulation in the management of urdhwaga Amlapitta. The study was a single arm, open clinical trial involving 133 patients of Amlapitta attending the OPD of All India Institute of Ayurveda, New Delhi, India. All patients were screened on the basis of classical clinical findings of Amlapitta and were administered with a combination of sutasekhar rasa (125 mg twice a day orally after principal meals) and Avipattikar choorna (5 g twice a day orally after principal meals) for 04 weeks period. Scoring scale based on classical clinical features of Amlapitta was adopted for the assessment of the disease. Routine pathological tests such as blood, urine, stool, etc. were carried out. During the study, 20 patients dropped out and 113 patients were followed.
INTRODUCTION
Amlapitta is a commonly encountered disease of Annavaha srotas (Gastrointestinal system). This disease has been described in detail in classical Ayurvedic texts like Kashyap samhita 1 , Yogaratnakar 2 and Bhaisajyaratnawali 3 etc. It is characterized by cardinal features like Avipaak (Indigestion), Klama (Tiredness), Utklesa (Nausea), Tikta-Amla Udgaar (Sour and bitter belching), Gauravata (Heaviness), Hrit-Kantha Daha (Heart and throat burn) and Aruchi (Anorexia) 4 Excess formation of vitiated pitta is thought to be the main pathological mechanism behind manifestation of this disease. The pitta is vitiated as a result of improper dietary and lifestyle habits. Clinical features of Amlapitta closely resemble with a condition known as Non ulcer dyspepsia or Functional dyspepsia. 5 The exact data on the prevalence of amlapitta is not available till date. However, Dyspepsia is reported to be accounting for only 5 % of consultation in family practice. 6 Community based studies reveal the prevalence of dyspepsia ranging from 19 % to as high as 41 % in the population. 7, 8 
Aims and objectives
The aim of this study is to evaluate the efficacy of the Avipattikar choorna and Sutasekhar rasa in management of urdhwaga Amlapitta.
MATERIALS AND METHODS Study design
Present study was an open, single arm clinical trial. Patients attending O.P.D. of All India Institute of Ayurveda, New Delhi, India with clinical symptoms of Urdhwaga Amlapitta were included into the study. A total of 133 patients of age above 18 years, of either sex, satisfying the inclusion criteria were finally enrolled in the study after through baseline screening. Informed consent was taken from the patient before including them in the trial. All the patients were administered with a combination of Sutasekhar Rasa and Avipattikar Churna 30 minutes after principal meals. The patients were registered and their data for demographic and clinical profile was maintained. The drugs were given with follow ups every week for duration of four weeks.
Inclusion criteria
Patients aged above 18 years of either sex, with cardinal features of amlapitta like Avipaak (Indigestion), Klama (Tiredness), Utklesa (Nausea), Tikta-Amla Udgaar (Sour and bitter belching), Gauravata (Heaviness), Hrit-Kantha Daha (Heart and throat burn), Aruchi (Anorexia) and those patients who were willing to give written consent to participate in the study were included in the study. (06) months were excluded from the study. A total of 133 patients of age above 18 years, of either sex, satisfying the inclusion criteria were finally enrolled in the study. During the study, 20 patients dropped out and only 113 were followed till the end.
Exclusion criteria

Trial drug and Posology
Patient enrolled in the study were administered with combination of sutasekhar rasa and avipattikar choorna. 
Duration of treatment: 04 weeks
Diet: Patients were kept under normal diet with special restriction of Spicy and oily diet. A copy of diet chart was given to each patient.
Follow-up:
The patients were followed-up once in seven days up to 28 days.
Laboratory Investigations
· Routine hematological investigations -Hb, TC, DC, E.S.R., P.C.V. · Urine examination -Routine and Microscopic. · Stool examination -Routine and Microscopic. All above mentioned laboratory investigations were carried out before and after treatment.
Criterion for assessment
Amlapitta was diagnosed according to the classical clinical features such as Avipaak (Indigestion), Klama (Tiredness), Utklesa (Nausea), Tikta-Amla Udgaar (Sour and bitter belching), Gauravata (Heaviness), Hrit-Kantha Daha (Heart and throat burn) and Aruchi (Anorexia) on four point grade scale (G 0 -G 3 ). 
Statistical analysis
The data generated during the study was subjected to Wilcoxon sum rank test to assess the statistical significance between before and after the administration of trial drugs.
OBSERVATIONS AND RESULTS
In the present study, it was observed that out of total 113 patients, 85 ( 
DISCUSSION
Amlapitta is a common gastric problem that is usually related with the food habits and lifestyle. In the present study, there were 85 males (75.22 %) and 51 females (24.78 %) in total. Previous study conducted by Baragi et al (2012) also reported male predominance in disease Amlapitta
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. It was observed that out of 113 patients, maximum patients i.e. 28 (24.78 %) belonged to age group 30-35 years. The mean age of patients was found to be mean age of 36.3 years. Madhyamavastha is considered as pitta prakopa vaya and thus, this age group is more prone to suffer to pitta predominant diseases. Regarding occupation wise distribution of patients, it was observed that, out of 113 patients, majority of patients (27.43 %) were involved in field work. On analyzing the symptomatology of amlapitta, Hrit Kantha Daha was found to be present in all (100 %) registered patients, while Tikta-amla udgaar in 92.92 % patients, Aruchi in 77.88 % patients, Avipaak in 63.72 % patients, Gurutaa in 62.83 % patients, Klama in 44.25 % patients and utklesha was found in 41.59 % patients. These findings are in correlation with previous study conducted by Kumar et al (2011) in which hrid daha was evident in 68.29 % patients, kukshi daha in 73.17 %, Urah daha in 51.22 % and kantha daha in 46.34 % patients suffering from amlapitta. 12 Significant improvement was observed following 04 weeks of administration of drugs in all assessment parameters of amlapitta. The trial drug Avipatikar churna has fourteen ingredients with having lavang (Syzygium aromaticum), trivrit (Ipomea turpethum) and sharkara (cane sugar) as its main constituents. It is indicated in indigestion, constipation, acidity, piles and diabetes. In amlapitta there is increase in amount of vitiated pitta that causes the symptoms of indigestion, sour and bitter belching, heartburn, anorexia etc. Avipattikar choorna mainly by its deepan, pachan and sarak guna normalizes the vitiated pitta and eliminate the extra pitta from the body by its laxative action. In the initial stage of Amlapitta, due to vitiation of Pitta there is manifestation of Vidagdhajeerna which may later causes inflammation and corrosion of the Sleshmadhara kala of the Amashaya i.e. mucous membrane of the stomach and duodenum 13 .
Studies on efficacy of Avipattikar churna on Amlapitta disease are very less. Research evidences shows that, Avipattikar churna possess significant gastro-protective activity. Oral administration of aqueous extract of Avipattikar churna in a dose of 500 mg/kg significantly provides protection against gastric lesions as compared to ranitidine in ibuprofen, ethanol and pylorus ligation induced ulcer models. Besides this, Histopathological examination of stomach mucosa showed the protective action against mucosal epithelial damage. Reduction in acid secretory parameters (i.e. total and free acid), gastric volume and gastric irritancy index was also demonstrated.
In vitro analysis reveals that Aqueous and methanolic extracts of Avipattikar churna possess antioxidant activity. 15 One of the ingredient of avipattikar churna is maricha (Piper nigrum). In a study, five phenolic amides from Piper nigrum found to possess significant antioxidant activities that are more effective than the naturally occurring antioxidant, alpha-tocopherol. 16 Another important ingredient of avipattikar choorna is Trivrit (Operculina terpethum Linn.)
Experimental study shows that hydroalcoholic and methanolic extract of stem bark extracts of Operculina turpethum possess enhanced ulcer preventive and protective activities when compared with the standard drug ranitidine. Extracts of Operculina turpethum were administered in a dose of 100 mg/kg, body weight orally and effects were evaluated employing aspirin pylorus ligation model in experimental rats. 17 Sutasekhar rasa (without gold) contain 16 ingredients. It is indicated in acidity, vomiting, gas formation, cough, sprue and diarrhea. It has anti-secretory property along with this it also normalizes the vitiated pitta of the body especially of GI tract when there is hyper secretion of acid in the tract it reduces its secretion. The Bhavna dravya (triturating medium) of trial drug Sutasekhar Rasa is Bhringaraj (Eclipta alba). The disease Amlapitta manifests as a result of abnormal functioning of pitta and particularly, the dravatva guna of pitta is increased. 18 The drug Bhringaraj (Eclipta alba) possess ruksha and ushna properties 19 and by virtue of both these properties, it reduces the abnormally increased dravatva of pitta, and helps in managing amlapitta. A recently randomized open clinical trial reported significant improvement in amlapitta features with administration of Bhringaraj tablets for duration of 04 weeks. 20 Other ingredients of sutasekhar rasa like Dhatura, Vatsanabh also helps in reducing the dravatva of the vitiated pitta and thus managing amlapitta. The role of pathya diet is the most vital step in the management of Amlapitta. Thus, the patients were instructed about the proper dietetic regimen to follow. In pathya, they were advised to take coconut water, unripe coconut, coconut petha (Sweet made up of coconut) (Cocos nucifera) milk, ghee, old rice, mix dal (Legumes), roti, vegetable like patola (Trichosanthes dioica) etc. and fruits like apple, banana, pomegranate etc. In apathy ,it was advised not to take spicy food, oily food, fried food, street road food, sour item like vinegar, lemon juice, curd, tomato etc, more salty food, bitter like chillies etc, ginger, garlic hot drinks like coffee, tea, tobacco, alcohol, Betel leaves chewing was also not permitted. It was observed that when the patient were given the treatment with advice to follow the pathya and apathy, their recovery from the disease was very much satisfactory and also there was reduced chance of recurrence of the disease.
CONCLUSION
Amlapitta is a chronic recurring condition of gastrointestinal system and affects quality of life of patients. It is caused by the faulty life style habits like Ati Lavan-Amla-Tiksha ahaar sevan (excessive intake of salty, sour, pungent food articles), Ati ushna bhojan (excessive intake of hot food stuff), Irregular diet, Raatri jaagran (Not sleeping at night), Vega vidhaarana (holding of natural urges) and Diva swapna (Day time sleep (Table 1 ). This causes vitiation of the dosha (Pitta) in body and ultimately leads to manifestation of the disease. Young age people are more prone to suffer from this disease as evident from the present study as well as prior researches on this disease. Addiction like tea, smoking and Tobacco chewing play an important role in causing and aggravating the disease. (Table 1) The combination of avipattikar churna with sutasekhar rasa is very effective in managing urdhwaga amlapitta. Both the drugs are free from side effects. Moreover, by abiding the Pathya and avoiding Apathya aahaar-vihaar patients have faster recovery and have reduced at chance of recurrence.
